Transaction · 0001610717-26-000359

Teichmann Sarah A.

Teichmann Sarah A., DIR, reported an open-market or private sale at 10x Genomics, Inc. involving 5278.000000 shares for an estimated $302376.62. Reported holdings after the transaction were 30331.000000 shares. The stored filing text includes a detected 10b5-1 reference.

Open-market sellSEC transaction code SDIR
TXG10x Genomics, Inc.
Filing timeAug 17
Trade dateAug 13, 2026
Filing · SECView on SEC
InsiderProfile

Price performance since filing

Close on the filing date, the pre-filing context, and the forward return at standard windows
Price at filing
$57.99
Pre-filing
1mo ago -21.0%1w ago -21.4%1d ago -0.4%
Returns since
7d +10.0%30d +3.4%90d +3.4%180d +3.4%1y +3.4%

TXG price since this filing

30 days of pre-filing context and vertical markers at the filing date plus 7d / 30d / 90d / 180d / 1y afterwards
TXG since 2026-08-17Filed 18 days ago · 30 days of pre-filing context shaded
Loading…
Filing datePost-filing windows (7d, 30d, 90d, 180d, 1y)30 days of pre-filing context

Transaction facts

Stored Form 4 columns with their raw values

Non-derivative
Type
Sell
Code S
Identifier
0001610717-26-000359
Class A Common Stock
Transaction date
Aug 13, 2026
Filed Aug 17, 2026, 08:08 PM · 4d delay
Shares
5.27k sh
$5.72k per share
Estimated value
-$30.2M
Computed from shares × price
Holdings after
30.3k sh
Direct

Filing signal explanations

Badges describe filing facts only — not predictions.

Cluster 14dRepeat 30dPattern $10.0MLarge $100M
Direct Ownership 10b5-1 Detected
-4score
Filing-only score

-4

Compact filing score computed from stored Form 4 facts. Version v1.

Neutral filing signal

This filing is broadly neutral on the filing-only scale. The Form 4 facts do not strongly tilt positive or negative.

Reported relationships & other filings

Form 4 relationship flags and nearby filing context

Reported roles

No officer title

Officer NoDirector Yes10% NoOther No
Footnotes & amended
  1. F1

    The sale was effected pursuant to the Reporting Person's Rule 10b5-1 trading plan, adopted on May 14, 2026.

Original filing · 0001610717-26-000359
Related transactions

0 other filings

Same reporting owner
Recent company activity

0 recent txs

TXG